| Home | About DNDi | Diseases and Projects | Treatments | Advocacy | News | Support DNDi |
ISID-NTD Conference
International Society of Infectious Diseases-Neglected Tropical Diseases (ISID-NTD) Conference, July 8-10, 2011, Boston, MA
At the inaugural ISID-NTD Conference, DNDi announced the first R&D project in its new filarial (helminth) parasitic-worm drug portfolio to address unmet needs of patients in Africa and Asia. This first project is focused on developing flubendazole, a macrofilaricide targeting adult worms, for the treatment of onchocerciasis (river blindness) and lymphatic filariasis (elephantiasis), co-infected with loiasis (Loa loa, or African eye worm).
Read the press announcement (PDF)
Read the PLoS Medicine guest blog by DNDi Executive Director Bernard Pecoul and Sabin Vaccine Institute President Peter Hotez, released on the first day of the ISID-NTD conference.
Dr. Manica Balasegaram speaking about DNDi's drug-development portfolio, July 9, 2011, Boston (credit: DNDi / Oliver Yun)